{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:42:01Z","timestamp":1787496121897,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.ygyno.2013.06.032","type":"journal-article","created":{"date-parts":[[2013,6,30]],"date-time":"2013-06-30T05:31:14Z","timestamp":1372570274000},"page":"489-492","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Reviewing the molecular mechanisms which increase endometrial cancer (EC) risk in women with polycystic ovarian syndrome (PCOS): Time for paradigm shift?"],"prefix":"10.1016","volume":"131","author":[{"given":"Mohamad N.","family":"Shafiee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jafaru","family":"Abu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Atiomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2013.06.032_bb0005","series-title":"UK Cancer Incidence (2010) and Mortality (2010) Summary","author":"Cancer Research UK","year":"2012"},{"issue":"2\u20133","key":"10.1016\/j.ygyno.2013.06.032_bb0010","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0090-8258(74)90003-1","article-title":"Risk factors for endometrial cancer","volume":"2","author":"Macmahon","year":"1974","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.ygyno.2013.06.032_bb0015","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/humrep\/des042","article-title":"Evaluating the association between endometrial cancer and polycystic ovary syndrome","volume":"27","author":"Haoula","year":"2012","journal-title":"Hum Reprod"},{"issue":"9371","key":"10.1016\/j.ygyno.2013.06.032_bb0020","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/S0140-6736(03)13409-5","article-title":"Polycystic ovary syndrome and endometrial carcinoma","volume":"361","author":"Hardiman","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2013.06.032_bb0025","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1055\/s-0029-1211234","article-title":"Estrogen use and cancer risk: a review","volume":"101","author":"Lupulescu","year":"1993","journal-title":"Exp Clin Endocrinol"},{"issue":"11","key":"10.1016\/j.ygyno.2013.06.032_bb0030","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJMra072067","article-title":"Epigenetic in cancer","volume":"358","author":"Esteller","year":"2008","journal-title":"N Eng J Med"},{"key":"10.1016\/j.ygyno.2013.06.032_bb0035","doi-asserted-by":"crossref","first-page":"738274","DOI":"10.1155\/2012\/738274","article-title":"Endometrial cancer and hypermethylation: regulation of DNA and MicroRNA by epigenetics","volume":"2012","author":"Banno","year":"2012","journal-title":"Biochem Res Int"},{"issue":"12","key":"10.1016\/j.ygyno.2013.06.032_bb0040","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1097\/PAS.0b013e3181bc9866","article-title":"Endometrial carcinomas in women aged 40years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset","volume":"33","author":"Garg","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ygyno.2013.06.032_bb0045","first-page":"774","article-title":"Insulin resistance and the polycystic ovarian syndrome: mechanism and implications for pathogenesis","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ygyno.2013.06.032_bb0050","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0002-9378(90)90838-X","article-title":"Estrogen replacement therapy and the risk of endometrial cancer: remaining controversies","volume":"162","author":"Rubin","year":"1990","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ygyno.2013.06.032_bb0055","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1079\/BJN20051475","article-title":"The optimal diet for women with polycystic ovary syndrome?","volume":"94","author":"Marsh","year":"2005","journal-title":"Br J Nutr"},{"issue":"1","key":"10.1016\/j.ygyno.2013.06.032_bb0060","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1210\/jcem-67-1-144","article-title":"Hyperinsulinemia and stromal luteinization of the ovaries in postmenopausal women with endometrial cancer","volume":"67","author":"Nagamani","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ygyno.2013.06.032_bb0065","first-page":"363","article-title":"Cell cycle analysis of endometrial cancer cells in vitro treated with growth factor and steroid hormone","volume":"5","author":"Oyama","year":"1992","journal-title":"Hum Cell"},{"key":"10.1016\/j.ygyno.2013.06.032_bb0070","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/S0002-9378(87)80258-2","article-title":"The effect of insulin on aromatase activity in isolated human endimetrial glands and stroma","volume":"157","author":"Randolph","year":"1987","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ygyno.2013.06.032_bb0075","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1158\/2159-8290.CD-11-0039","article-title":"High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability","volume":"1","author":"Cheung","year":"2011","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ygyno.2013.06.032_bb0080","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0002-9378(85)90591-5","article-title":"In vitro binding of insulin and epidermal growth factor to human endometrium and endocervix","volume":"153","author":"Sheets","year":"1985","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2013.06.032_bb0085","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/0002-9378(91)90047-U","article-title":"Specific binding sites for insulin and insulin-like growth factor I in human endometrial cancer","volume":"165","author":"Nagamani","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2013.06.032_bb0090","first-page":"3019","article-title":"Insulin-like growth factor I receptors in normal and neoplastic human endometrium","volume":"50","author":"Talavera","year":"1990","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ygyno.2013.06.032_bb0095","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1210\/jc.2004-1676","article-title":"Dose-dependent insulin regulation of insulin-like growth factor binding protein-1 in human endometrial stromal cells is mediated by distinct signaling pathways","author":"Lathi","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ygyno.2013.06.032_bb0100","doi-asserted-by":"crossref","first-page":"235-44","DOI":"10.1016\/j.beem.2006.03.005","article-title":"Endometrium in PCOS: implantation and predisposition to endocrine CA","volume":"20","author":"Giudice","year":"2006","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.ygyno.2013.06.032_bb0105","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1046\/j.1471-0528.2003.02389.x","article-title":"Ovarian stromal hyperplasia and ovarian vein steroid levels in relation to endometrioid endometrial cancer","volume":"7","author":"Jongen","year":"2003","journal-title":"BJOG"},{"issue":"11","key":"10.1016\/j.ygyno.2013.06.032_bb0110","first-page":"652","article-title":"Expression of apoptosis regulatory protein bcl-2 and bax in endometrium of polycystic ovary syndrome","volume":"34","author":"Chen","year":"1999","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"issue":"12","key":"10.1016\/j.ygyno.2013.06.032_bb0115","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1093\/humrep\/del183","article-title":"Expression of molecules associated with tissue homeostasis in secretory endometria from untreated women with polycystic ovary syndrome","volume":"21","author":"Avellaira","year":"2006","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.ygyno.2013.06.032_bb0120","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ygyno.2006.09.003","article-title":"Reregulation of tissue homeostasis in endometria from patients with polycystic ovarian syndrome with and without endometrial hyperplasia","volume":"104","author":"Villavicencio","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2013.06.032_bb0125","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.canlet.2011.09.027","article-title":"Estrogen receptor-regulated microRNAs contribute to the BCL2\/BAX imbalance in endometrial adenocarcinoma and precancerous lesions","volume":"314","author":"Zhang","year":"2012","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ygyno.2013.06.032_bb0130","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.fertnstert.2010.12.027","article-title":"Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis","volume":"95","author":"Wild","year":"2011","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.ygyno.2013.06.032_bb0135","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3945\/an.111.001602","article-title":"Mechanisms of gene regulation by fatty acids","volume":"3","author":"Georgiadi","year":"2012","journal-title":"Adv Nutr"},{"issue":"12","key":"10.1016\/j.ygyno.2013.06.032_bb0140","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.4161\/cc.20811","article-title":"Repression of endometrial tumor growth by targeting SREBP1 and lipogenesis","volume":"11","author":"Li","year":"2012","journal-title":"Cell Cycle"},{"issue":"6","key":"10.1016\/j.ygyno.2013.06.032_bb0145","doi-asserted-by":"crossref","first-page":"6835","DOI":"10.1007\/s11033-012-1508-0","article-title":"Genetic variations in SREBP-1 and LXR\u03b1 are not directly associated to PCOS but contribute to the physiological specifics of the syndrome","volume":"39","author":"Knebel","year":"2012","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.ygyno.2013.06.032_bb0150","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrc1390","article-title":"Metabolic profiles of cancer cells","volume":"4","author":"Griffin","year":"2004","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"10.1016\/j.ygyno.2013.06.032_bb0155","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1210\/jc.2012-1490","article-title":"Analysis of serum metabolic profiles in women with endometrial cancer and controls in a population-based case-control study","volume":"97","author":"Gaudet","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ygyno.2013.06.032_bb0160","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00018-005-5471-y","article-title":"Unfaithfulness and promiscuity of a mutant androgen receptor in a hormone refractory prostate cancer","volume":"63","author":"Monge","year":"2006","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.ygyno.2013.06.032_bb0165","doi-asserted-by":"crossref","first-page":"e7075","DOI":"10.1371\/journal.pone.0007075","article-title":"Proteomic interrogation of androgen action in prostate cancer cells reveals roles of aminoacyl tRNA synthetases","volume":"4","author":"Vellaichamy","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2013.06.032_bb0170","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/nature07762","article-title":"Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression","volume":"457","author":"Sreekumar","year":"2009","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ygyno.2013.06.032_bb0175","first-page":"123","article-title":"Clinical applications of metabolomics in oncology: a review 2009","volume":"15","author":"Jennifer","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2013.06.032_bb0180","first-page":"96","article-title":"Endometrial gene expression in women with polycystic ovarian syndrome","volume":"20","author":"Pillay","year":"2005","journal-title":"Hum Reprod"},{"issue":"7","key":"10.1016\/j.ygyno.2013.06.032_bb0185","doi-asserted-by":"crossref","first-page":"638","DOI":"10.3109\/09513590.2013.777416","article-title":"Proteomic biomarkers of endometrial cancer risk in women with polycystic ovary syndrome (PCOS). A systematic review and biomarker database integration","volume":"29","author":"Galazis","year":"2013","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"10.1016\/j.ygyno.2013.06.032_bb0190","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/1099-1492(200008)13:5<271::AID-NBM646>3.0.CO;2-7","article-title":"Quantification of plasma lipids and apolipoproteins by use of proton NMR spectroscopy, multivariate and neural network analysis","volume":"13","author":"Bathen","year":"2000","journal-title":"NMR Biomed"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813008652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813008652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T18:50:57Z","timestamp":1539543057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825813008652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0090825813008652"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.06.032","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reviewing the molecular mechanisms which increase endometrial cancer (EC) risk in women with polycystic ovarian syndrome (PCOS): Time for paradigm shift?","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.06.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}